Targeted Oncology
Targeted Oncology
Targeted Oncology

Specialties

The Possibility for Immunotherapy in Neoadjuvant Bladder Cancer Treatment

Geoffrey Sklar, MD
Published Online:10:02 AM, Mon January 9, 2017

Geoffrey Sklar, MD, Chief Medical Officer, Chesapeake Urology Associates, discusses the possibility for immunotherapy as a neoadjuvant treatment in bladder cancer.
Publications